Product Information
LISDEXAMFETAMINE 30 MG CAPSULE is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $3.0366 per EA under NDC 42858016301. Its NADAC has been published 114 times since Apr 24, 2024.
Strength
30 mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858016301
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LISDEXAMFETAMINE DIMESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA215330On Market Since
1/30/2024
Pharmacological Classes
Price Statistics
The NADAC for LISDEXAMFETAMINE 30 MG CAPSULE has been published 114 times since Apr 24, 2024, and over the history we have for it it has declined 52.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.0366 per EA |
|---|---|
| All-time high | $6.3697 (May 15, 2024) |
| All-time low | $2.9584 (Mar 18, 2026) |
| 52-week high | $3.9018 |
| 52-week low | $2.9584 |
| Median price | $3.7780 |
| Average price | $4.0503 |
| Largest weekly change | +59.1% (Jun 19, 2024) |
| Weeks tracked | 114 |
| Tracking since | Apr 24, 2024 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LISDEXAMFETAMINE 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 30 MG CAPSULE, manufactured by Rhodes Pharmaceuticals L.P., is $3.0366 per EA (NDC 42858016301), effective Jun 24, 2026.
How has the price of LISDEXAMFETAMINE 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LISDEXAMFETAMINE 30 MG CAPSULE has declined 52.3%. It has been tracked across 114 weekly CMS publications since Apr 24, 2024.
What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 30 MG CAPSULE?
Since Apr 24, 2024, the NADAC for LISDEXAMFETAMINE 30 MG CAPSULE has ranged from a low of $2.9584 (Mar 18, 2026) to a high of $6.3697 (May 15, 2024), with a median of $3.7780 per EA.
Are there cheaper alternatives to LISDEXAMFETAMINE 30 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as LISDEXAMFETAMINE 30 MG CAPSULE, but none are currently priced below it.
Who manufactures LISDEXAMFETAMINE 30 MG CAPSULE?
LISDEXAMFETAMINE 30 MG CAPSULE (NDC 42858016301) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.
Related Drugs
Same classification